Oct 30, 2017 05:45 am UTC| Business
PARIS, Oct. 30, 2017 -- BIOPHYTIS (Euronext Growth Paris: ALBPS), a biotechnology company specializing in the development of drug candidates to treat age-related diseases, today announces the approval from the Food and...
Good Things Come in Pairs to EOS Inc. in Singapore
Oct 30, 2017 04:52 am UTC| Business
TAIPEI, Taiwan, Oct. 30, 2017 -- The international marketing teams of EOS Inc. gathered and celebrated the inspiring growth of the business again, in Singapore’s flagship store on August 28th. The visiting teams had...
INSYS Therapeutics to Record a Minimum Liability for Department of Justice Settlement in Q3 2017
Oct 30, 2017 00:45 am UTC| Business
PHOENIX, Oct. 29, 2017 -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”), today made the following statement about the Department of Justice (DOJ) investigation. In connection with our cooperation...
INSYS Therapeutics Affirms Its Commitment to Sustainable Future Growth
Oct 30, 2017 00:00 am UTC| Business
PHOENIX, Oct. 29, 2017 -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”), today released the following statement from its president and chief executive officer, Saeed Motahari: “While we are...
Oct 30, 2017 00:00 am UTC| Business
NEW YORK, Oct. 29, 2017 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Navient Corporation (NASDAQ:NAVI) who purchased shares between February 25, 2016 and...
INSYS Therapeutics Announces Resignation of Patrick P. Fourteau from Board of Directors
Oct 29, 2017 23:30 pm UTC| Business
PHOENIX, Oct. 29, 2017 -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”) today accepted the resignation of Patrick P. Fourteau from its Board of Directors effective immediately. Mr. Fourteau cited...
INSYS Therapeutics Founder Dr. John N. Kapoor Steps Down from Board of Directors
Oct 29, 2017 22:30 pm UTC| Business
PHOENIX, Oct. 29, 2017 -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”) today accepted the resignation of the company’s founder, Dr. John N. Kapoor, from its Board of Directors. The full text of Dr....